Germline deletions occur in about 1–3% of the Lynch syndrome families and lead to epigenetic silencing of MSH2. Germline mutations in MSH6 and PMS2 are less common, accounting for about 7–10% and fewer than 5% of all MMR gene mutations, respectively 5, 6. This evidence concerns the gene PMS2 and Lynch syndrome.